FDA
ProQR Receives Rare Pediatric Disease Designation from FDA for QR-421a
ProQR Therapeutics
PR-M01-20-NI-044Jan 30, 2020
Ophthalmology
Tackling Genetic Eye Diseases with Novel RNA Therapies
Daniel A. de Boer
ProQR Therapeutics
PAP-Q4-19-CL-027Dec 06, 2019